AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$162.52
−1.37%Forward multiples
Based on analyst estimates
- P/E forward
- 15.32x
- P/E 2026E
- 15.83x
- P/E 2027E
- 14.11x
- P/E 2028E
- 12.69x
- P/S forward
- 3.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.18x
- PEG TTM
- 0.42x
- Price / book
- 5.02x
- Price / sales
- 4.11x
- Price / cash flow
- 18.25x
Enterprise value
- Enterprise value
- $279.4B
- EV / sales
- 4.55x
- EV / EBITDA
- 13.51x
- EV / EBIT
- 20.00x
- Market cap
- $252.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026